Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS research · 2011-08-15

Clinical Trial Update: Treatment of Depression in Parkinson's Disease [Phase 2]

View source ↗

Summary

A Phase 2 clinical trial is evaluating treatment for depression in Parkinson's disease. The current status is unknown.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Snippet

Sponsor: Xuanwu Hospital, Beijing | Conditions: Depression in Parkinson's Disease | Phase 2 | Status: UNKNOWN